PKCγ mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling

被引:61
作者
Verbeek, Dineke S. [1 ]
Goedhart, Joachim [2 ]
Bruinsma, Laurie [1 ]
Sinke, Richard J. [3 ]
Reits, Eric A. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, Ctr Adv Microscopy, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Utrecht, Dept Biomed Genet, Univ Med Ctr Utrecht, NL-3508 TC Utrecht, Netherlands
关键词
spinocerebellar ataxia; protein kinase C gamma; GFP; FLIM; FRET;
D O I
10.1242/jcs.027698
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Spinocerebellar ataxia type 14 (SCA14) is a neurodegenerative disorder caused by mutations in the neuronal-specific protein kinase C gamma (PKC gamma) gene. Since most mutations causing SCA14 are located in the PKC gamma C1B regulatory subdomain, we investigated the impact of three C1B mutations on the intracellular kinetics, protein conformation and kinase activity of PKC gamma in living cells. SCA14 mutant PKC gamma proteins showed enhanced phorbol-ester-induced kinetics when compared with wild-type PKC gamma. The mutations led to a decrease in intramolecular FRET of PKC gamma, suggesting that they 'open' PKC gamma protein conformation leading to unmasking of the phorbol ester binding site in the C1 domain. Surprisingly, SCA14 mutant PKC gamma showed reduced kinase activity as measured by phosphorylation of PKC reporter MyrPalm-CKAR, as well as downstream components of the MAPK signaling pathway. Together, these results show that SCA14 mutations located in the C1B subdomain 'open' PKC gamma protein conformation leading to increased C1 domain accessibility, but inefficient activation of downstream signaling pathways.
引用
收藏
页码:2339 / 2349
页数:11
相关论文
共 67 条
[1]   A novel H101Q mutation causes PKCγ loss in spinocerebellar ataxia type 14 [J].
Alonso, I ;
Costa, C ;
Gomes, A ;
Ferro, A ;
Seixas, AI ;
Silva, S ;
Cruz, VT ;
Coutinho, P ;
Sequeiros, J ;
Silveira, I .
JOURNAL OF HUMAN GENETICS, 2005, 50 (10) :523-529
[2]   Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains [J].
Ananthanarayanan, B ;
Stahelin, RV ;
Digman, MA ;
Cho, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46886-46894
[3]   Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity [J].
Apostol, BL ;
Illes, K ;
Pallos, J ;
Bodai, L ;
Wu, J ;
Strand, A ;
Schweitzer, ES ;
Olson, JM ;
Kazantsev, A ;
Marsh, JL ;
Thompson, LM .
HUMAN MOLECULAR GENETICS, 2006, 15 (02) :273-285
[4]   Emergent properties of networks of biological signaling pathways [J].
Bhalla, US ;
Iyengar, R .
SCIENCE, 1999, 283 (5400) :381-387
[5]   Analysis by fluorescence resonance energy transfer of the interaction between ligands and protein kinase Cδ in the intact cell [J].
Braun, DC ;
Garfield, SH ;
Blumberg, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) :8164-8171
[6]   A monomeric red fluorescent protein [J].
Campbell, RE ;
Tour, O ;
Palmer, AE ;
Steinbach, PA ;
Baird, GS ;
Zacharias, DA ;
Tsien, RY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :7877-7882
[7]   Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice [J].
Chen, C ;
Kano, M ;
Abeliovich, A ;
Chen, L ;
Bao, SW ;
Kim, JJ ;
Hashimoto, K ;
Thompson, RF ;
Tonegawa, S .
CELL, 1995, 83 (07) :1233-1242
[8]   Missense mutations in the regulatory domain of PKCγ:: A new mechanism for dominant nonepisodic cerebellar ataxia [J].
Chen, DH ;
Brkanac, Z ;
Verlinde, CLMJ ;
Tan, XJ ;
Bylenok, L ;
Nochlin, D ;
Matsushita, M ;
Lipe, H ;
Wolff, J ;
Fernandez, M ;
Cimino, PJ ;
Bird, TD ;
Raskind, WH .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (04) :839-849
[9]   Protein-protein interactions in the regulation of the extracellular signal-regulated kinase [J].
Chuderland, D ;
Seger, R .
MOLECULAR BIOTECHNOLOGY, 2005, 29 (01) :57-74
[10]   Chronic activation of ERK and neurodegenerative diseases [J].
Colucci-D'Amato, L ;
Perrone-Capano, C ;
di Porzio, U .
BIOESSAYS, 2003, 25 (11) :1085-1095